Fresenius Group

Committed to Life


The Healthcare Group

The Fresenius Group comprises the Operating Companies Fresenius Kabi and Fresenius Helios as well as the Investment Companies Fresenius Medical Care and Fresenius Vamed.

  • Fresenius Kabi supplies healthcare products for critically and chronically ill patients
  • Fresenius Helios is Europe’s leading private hospital operator 

Fresenius continuously develops its business areas. With the #FutureFresenius program, the focus will be on three therapy platforms: 

  • (Bio)Pharma including clinical nutrition
  • MedTech
  • Care Provision

With these platforms, Fresenius caters to major trends in healthcare and becomes a more therapy-focused company. The health and quality of life of patients who the company serves with high-quality, affordable products and services is at the core. 

At Fresenius, the patient always comes first. For more than 100 years now we have been working to save lives and improve the quality of life of our critically and chronically ill patients. A clear focus on innovation and efficiency has helped us to make world-class therapies accessible to a steadily increasing number of people. 




A 100-year heritage of caring

In 1912, the pharmacist Dr. Eduard Fresenius, proprietor of the Hirsch Pharmacy, established the pharmaceutical company Dr. E. Fresenius, expanding the pharmacy laboratory into a small manufacturing operation. Its main products were pharmaceutical specialties such as injection solutions, serologic reagents, and Bormelin nasal ointment. In 1952, Else Fernau (later Else Kröner), the foster daughter of Eduard Fresenius, assumed responsibility for the business, and began the transformation into the company as it stands today as a global producer of essential medicines and technologies and a leading provider of advanced medical care in Europe.